IIA
TXMD icon

IPG Investment Advisors’s TherapeuticsMD TXMD Stock Holding History

IPG Investment Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-612
Closed -$22.7K – 235
2021
Q3 		$22.7K Hold
612
– – 0.01% 133
2021
Q2 		$36.4K Hold
612
– – 0.01% 145
2021
Q1 		$41K Hold
612
– – 0.01% 188
2020
Q4 		$37K Hold
612
– – 0.01% 167
2020
Q3 		$48.4K Hold
612
– – 0.01% 149
2020
Q2 		$38.3K Hold
612
– – 0.01% 128
2020
Q1 		$32.4K Buy
612
+200
+49% +$19.8K 0.01% 122
2019
Q4 		$49.9K Buy
412
+200
+94% +$28.8K 0.02% 127
2019
Q3 		$38.5K Buy
+212
New +$29.9K 0.01% 126

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IPG Investment Advisors's TXMD Position: Q4 2021 in Review

IPG Investment Advisors sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 612 shares — an estimated $22.7K sold.

IPG Investment Advisors first reported a position in TXMD in Q3 2019 and held it in 9 quarters. The position peaked at $49.9K in Q4 2019. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • IPG Investment Advisors reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • IPG Investment Advisors sold 612 TherapeuticsMD shares in Q4 2021, an estimated $22.7K.
  • IPG Investment Advisors first reported a position in TherapeuticsMD in Q3 2019 and held it in 9 quarters.
  • IPG Investment Advisors's TherapeuticsMD position peaked at $49.9K in Q4 2019.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on IPG Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.